However, it is difficult to distinguish breast cancers from sclerosing adenosis with USE and α-SMA is also expressed in sclerosing adenosis, which might interfere with the consistency between USE scoring and myofibroblast distribution. This evidence concerns the gene ACTA1 and breast carcinoma.